Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease-Reference-Cited by-同舟云学术

Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease

Published:2019-06-10 Issue:7 Volume:129 Page:2760-2774
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Sofi M. Hanief,Wu Yongxia,Schutt Steven D.^ORCID,Dai Min,Daenthanasanmak Anusara,Heinrichs Voss Jessica,Nguyen Hung^ORCID,Bastian David,Iamsawat Supinya,Selvam Shanmugam Panneer,Liu Chen,Maulik Nilanjana,Ogretmen Besim^ORCID,Jin Junfei,Mehrotra Shikhar,Yu Xue-Zhong

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/122899/files/pdf

Reference60 articles.

1. Graft-versus-leukemia effects of transplantation and donor lymphocytes

2. Haematopoietic cell transplantation as immunotherapy

3. Immunobiology of Allogeneic Hematopoietic Stem Cell Transplantation

4. A biomarker panel for acute graft-versus-host disease;Paczesny;Blood,2009

5. Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. hPMSCs prevent erythrocytes dysfunction caused by graft versus host disease via promoting GSH synthesis;International Immunopharmacology;2024-09

2. hUCMSC-derived exosomes protect against GVHD-induced endoplasmic reticulum stress in CD4+ T cells by targeting the miR-16-5p/ATF6/CHOP axis;International Immunopharmacology;2024-06

3. Advances in Nanoplatforms for Immunotherapy Applications Targeting the Tumor Microenvironment;Molecular Pharmaceutics;2024-01-03

4. Targeting PRMT1 prevents acute and chronic graft-versus-host disease;Molecular Therapy;2023-11

5. Donor T cell STAT3 deficiency enables tissue PD-L1–dependent prevention of graft-versus-host disease while preserving graft-versus-leukemia activity;Journal of Clinical Investigation;2023-08-01